Thomas P. O'Neil

Entity
Individual
Business address
Satsuma Pharmaceuticals, Inc., 400 Oyster Point Boulevard, Suite 221, 94080 South San Francisco, CA
Signature Ownership
/s/ Thomas P. O'Neil
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Thomas P. O'Neil has filed 18 SEC EDGAR filings since 5/14/2015

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION Jun 8, 2023 Jun 6, 2023 001-39041
4 Open Document Open Filing FORM 4 Jun 7, 2022 Jun 3, 2022 001-39041
4 Open Document Open Filing FORM 4 Dec 7, 2020 Dec 3, 2020 001-39041
4 Open Document Open Filing FORM 4 Sep 3, 2020 Sep 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Aug 7, 2020 Aug 5, 2020 001-39041
4 Open Document Open Filing FORM 4 Jul 2, 2020 Jul 1, 2020 001-39041
4 Open Document Open Filing FORM 4 Jun 24, 2020 Jun 23, 2020 001-39041
4 Open Document Open Filing FORM 4 Jun 2, 2020 Jun 1, 2020 001-39041
4 Open Document Open Filing FORM 4 May 21, 2020 May 20, 2020 001-39041
4 Open Document Open Filing FORM 4 Mar 12, 2020 Mar 11, 2020 001-39041
4 Open Document Open Filing FORM 4 Mar 6, 2020 Mar 4, 2020 001-39041
3 Open Document Open Filing FORM 3 SUBMISSION Sep 12, 2019 Sep 12, 2019 001-39041
4 Open Document Open Filing FORM 4 SUBMISSION Aug 17, 2018 Aug 15, 2018 001-37852
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2018 Feb 28, 2018 001-37852
4 Open Document Open Filing FORM 4 SUBMISSION Dec 20, 2017 Dec 18, 2017 001-37852
4 Open Document Open Filing FORM 4 SUBMISSION Oct 13, 2016 Oct 11, 2016 001-37852
3 Open Document Open Filing FORM 3 SUBMISSION Aug 10, 2016 Aug 10, 2016 001-37852
3 Open Document Open Filing FORM 3 SUBMISSION May 14, 2015 May 14, 2015 001-37383